FOLD - AMICUS THERAPEUTICS, INC.
14.33
-0.010 -0.070%
Share volume: 5,574,104
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$14.34
-0.01
0.00%
Summary score
28%
Profitability
0%
Dept financing
42%
Liquidity
75%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.07%
Return on assets
-5.29%
Return on sales
-1254.88%
Return on invested capital
-17.47%
Total debt ratio
62.03%
Debt ratio change over timeo
0%
Current Ratio
3.3%
Quick Ratio
3.25%
Cash Position Ratio
0.76%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.82%
Return on assets
-5.56%
Return on sales
-992.21%
Return on invested capital
-22.23%
Total debt ratio
61.34%
Debt ratio change over timeo
0%
Current Ratio
3.62%
Quick Ratio
3.57%
Cash Position Ratio
0.85%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-27.26%
Return on assets
-7.94%
Return on sales
-497.1%
Return on invested capital
-61.49%
Total debt ratio
39.82%
Debt ratio change over time
0%
Current Ratio
6.32%
Quick Ratio
6.22%
Cash Position Ratio
0.94%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FOLD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -18.07% | 4.12% | 5.6% | 28.84% |
| Return on assets | -5.29% | 2.87% | 3.58% | 3.88% |
| Return on sales | -1254.88% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | -17.47% | 4.34% | 6.5% | 4.27% |
| Profitability | 0% | 52% | 72% | 91% |
| Total debt ratio | 62.03% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 42% | 17% | 14% | 25% |
| Current Ratio | 3.62% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 3.57% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.85% | 0.31% | 0.62% | 0.55% |
| Liquididy | 75% | 29% | 51% | 44% |
| Short-term ratios | FOLD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -19.82% | 3.9% | 5.53% | 29.97% |
| Return on assets | -5.56% | 2.93% | 3.51% | 3.83% |
| Return on sales | -992.21% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | -22.23% | 4.21% | 6.14% | 4.25% |
| Profitability | 0% | 53% | 71% | 92% |
| Total debt ratio | 61.34% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 42% | 18% | 14% | 25% |
| Current Ratio | 3.62% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 3.57% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.85% | 0.31% | 0.62% | 0.55% |
| Liquididy | 75% | 25% | 43% | 37% |